Case Report: A Rare Case of Iodixanol-Induced Anaphylactic Shock in Cerebral Angiography

References

• Sahoo A, Abdalkader M, Saatci I, et al. History of Neurointervention. Semi Neurol. 2023;43(03):454–465. doi:10.1055/s-0043-1771455
   PubMed Web of Science ®Google Scholar
• Batista S, Oliveira LB, Diniz JBC, et al. Transradial versus transfemoral approach in cerebral angiography: a meta-analysis. Inter Neuroradiol. 2023;2:1.
   Google Scholar
• Muschick P, Wehrmann D, Schuhmann-Giampieri G, Krause W. Cardiac and hemodynamic tolerability of iodinated contrast media in the anesthetized rat. Invest Radiol. 1995;30(12):745–753. doi:10.1097/00004424-199512000-00009
   PubMed Web of Science ®Google Scholar
• Costa N. Understanding contrast media. J Infus Nurs. 2004;27(5):302–312. doi:10.1097/00129804-200409000-00004
   PubMedGoogle Scholar
• Jost G, Lengsfeld P, Lenhard DC, Pietsch H, Hütter J, Sieber MA. Viscosity of iodinated contrast agents during renal excretion. Eur. J. Radiol. 2011;80(2):373–377. doi:10.1016/j.ejrad.2011.02.003
   PubMed Web of Science ®Google Scholar
• D D’Avella RC, Albiero F, Piscitelli G, et al. Effect of intracarotid injection of iopamidol on local cerebral glucose utilization in rat brain. AJNR Am J Neuroradiol. 1989;10(4):797–801.
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson S-G, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491–499. doi:10.1056/NEJMoa021833
   PubMed Web of Science ®Google Scholar
• Häussler MD. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations. Acta Radiol. 2010;51(8):924–933. doi:10.3109/02841851.2010.504739
   PubMed Web of Science ®Google Scholar
• Zhang BC, Hou L, Lv B, Xu YW. Post-marketing surveillance study with iodixanol in 20 185 Chinese patients from routine clinical practices. Br J Radiol. 2014;87(1034):1034. doi:10.1259/bjr.20130325
   Web of Science ®Google Scholar
• Gharekhanloo F, Torabian S. Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iran J Radiol. 2012;9(2):63–66. doi:10.5812/iranjradiol.7696
   PubMed Web of Science ®Google Scholar
• Poirier VC, Hecht ST, Nemzek WR, Nemzek WR. Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography. Acad Radiol. 1996;3:S495–S499. doi:10.1016/S1076-6332(05)80365-4
   PubMed Web of Science ®Google Scholar
• Matthew S, Davenport RHC, Elaine M, James H. Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology. 2009;253(2):372–379. doi:10.1148/radiol.2532090465
   PubMed Web of Science ®Google Scholar
• Adam N, Williams JMK. Radiocontrast-induced anaphylaxis despite pretreatment and use of iso-osmolar contrast. Ann Allergy Asthma Immunol. 2007;99(5):467–468. doi:10.1016/S1081-1206(10)60574-1
   PubMed Web of Science ®Google Scholar
• Qiu L, Cui Q, Gong X, Zhou H. Anaphylaxis following contrast-enhanced CT with iodixanol: a case report and literature review. J Asthma Aller. 2023;16:195–200. doi:10.2147/JAA.S386811
   PubMed Web of Science ®Google Scholar
• Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001–1006. doi:10.7326/0003-4819-140-12-200406150-00009
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JA. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol. 2001;11(9):1720–1728. doi:10.1007/s003300000778
   PubMed Web of Science ®Google Scholar
• Bruhns P, Chollet-Martin S. Mechanisms of human drug-induced anaphylaxis. J Allergy Clin Immunol. 2021;147(4):1133–1142. doi:10.1016/j.jaci.2021.02.013
   PubMed Web of Science ®Google Scholar
• Cianferoni A. Non–IgE-mediated anaphylaxis. J Allergy Clin Immunol. 2021;147(4):1123–1131. doi:10.1016/j.jaci.2021.02.012
   PubMed Web of Science ®Google Scholar
• Bao C, Chen O, Sheng H, et al. A mast cell–thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis. Sci Immunol. 2023;8(81):eadc9417. doi:10.1126/sciimmunol.adc9417
   PubMed Web of Science ®Google Scholar
• Engeroff P, Plattner K, Storni F, et al. Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model. J Allergy Clin Immunol. 2021;147(4):1430–1441. doi:10.1016/j.jaci.2020.11.031
   PubMed Web of Science ®Google Scholar
• Baba Y, Nishida K, Fujii Y, Hirano T, Hikida M, Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat Immunol. 2007;9(1):81–88. doi:10.1038/ni1546
   PubMed Web of Science ®Google Scholar
• Bansal G, Xie Z, Rao S, Nocka KH, Druey KM. Suppression of immunoglobulin E–mediated allergic responses by regulator of G protein signaling 13. Nat Immunol. 2007;9(1):73–80. doi:10.1038/ni1533
   PubMed Web of Science ®Google Scholar
• Obata K, Mukai K, Tsujimura Y, et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood. 2007;110(3):913–920. doi:10.1182/blood-2007-01-068718
   PubMed Web of Science ®Google Scholar
• Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity. 2008;28(4):581–589. doi:10.1016/j.immuni.2008.02.008
   PubMed Web of Science ®Google Scholar
• Pennington LF, Gasser P, Brigger D, Guntern P, Eggel A, Jardetzky TS. Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions. J Allergy Clin Immunol. 2021;148(4):1049–1060. doi:10.1016/j.jaci.2021.03.050
   PubMed Web of Science ®Google Scholar
• Zimmer J, Kim M-H, Lee S-Y, et al. Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock. PLoS One. 2014;9(6). doi:10.1371/journal.pone.0108414
   Web of Science ®Google Scholar
• Ahn Y-H, Koh Y-I, Kim J-H, et al. The Potential Utility of Iodinated Contrast Media (ICM) Skin Testing in Patients with ICM Hypersensitivity. J Korean Med Sci. 2015;30(3):245–251. doi:10.3346/jkms.2015.30.3.245
   PubMed Web of Science ®Google Scholar
• Chen Q-L, Zhao X-Y, Wang X-M, et al. Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China. Therap Clin Risk Manage. 2017;13:565–573. doi:10.2147/TCRM.S134265
   PubMed Web of Science ®Google Scholar
• Doña I, Bogas G, Salas M, et al. Hypersensitivity reactions to multiple iodinated contrast media. Front Pharmacol. 2020;11:575437. doi:10.3389/fphar.2020.575437
   PubMed Web of Science ®Google Scholar
• Kvedariene V, Orvydaite M, Petraityte P, Rudyte J, Edvardas Tamosiunas A. Inherent clinical properties of non‐immediate hypersensitivity to iodinated contrast media. Int J Clin Pract. 2021;75(11):e14766. doi:10.1111/ijcp.14766
   PubMed Web of Science ®Google Scholar
• Hitomi K, Tahara-Hanaoka S, Someya S, et al. An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E–mediated immediate hypersensitivity reactions. Nat Immunol. 2010;11(7):601–607. doi:10.1038/ni.1886
   PubMed Web of Science ®Google Scholar
• Rosado Ingelmo A, Doña Diaz I, Cabañas Moreno R, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Invest Allergol Clin Immunol. 2016;26(3):144–155. doi:10.18176/jiaci.0058
   PubMed Web of Science ®Google Scholar
• Beck SC, Wilding T, Buka RJ, Baretto RL, Huissoon AP, Krishna MT. Biomarkers in human anaphylaxis: a critical appraisal of current evidence and perspectives. Front Immunol. 2019;10:10. doi:10.3389/fimmu.2019.00010
   PubMed Web of Science ®Google Scholar
• Allen JD, Jaffer ZM, Park S-J, et al. p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood. 2009;113(12):2695–2705. doi:10.1182/blood-2008-06-160861
   PubMed Web of Science ®Google Scholar
• Kim S-R, Park KH, Hong YJ, Oh YT, Park J-W, Lee J-H. Intradermal testing with radiocontrast media to prevent recurrent adverse reactions. Am J Roentgenol. 2019;213(6):1187–1193. doi:10.2214/AJR.19.21547
   PubMed Web of Science ®Google Scholar
• Soffer G, Cohen B, Toh J, Edelman D, Garg K, Jariwala S. Successful graded dose challenge to iodixanol radiocontrast media in a patient with delayed anaphylaxis to iohexol. Vascu Endovasc Surg. 2017;52(1):59–60. doi:10.1177/1538574417736420
   PubMed Web of Science ®Google Scholar
• Lin X, Yang J, Weng L, Lin W. Differences in hypersensitivity reactions to iodinated contrast media: analysis of the us food and drug administration adverse event reporting system database. J Allergy Clin Immunol. 2023;11(5):1494–1502.e1496. doi:10.1016/j.jaip.2023.01.027
   Web of Science ®Google Scholar